Follow on Google News News By Tag * DDMAC Compliance * DDMAC-01 * FDA's DDMAC Requirements * Drug Marketing * Strategic Initiatives * More Tags... Industry News News By Place Country(s) Industry News
Follow on Google News | FDA's DDMAC Compliance: Current Issues and Emerging Perspectives - Webinar By ComplianceOnlineThis DDMAC Compliance training will cover regulations, their application and enforcement activities as they relate to FDA’s Division of Drug Marketing, Advertising and Communications.
By: ComplianceOnline This course provides a survey of the regulations, their application and enforcement activities as they relate to FDA’s Division of Drug Marketing, Advertising and Communications. With that background, we will explore current issues in drug product promotion, including web-based activities. By the end of this webinar, the participant will have a basic understanding of vocabulary and the context by which the Division of Drug Marketing and Advertising (DDMAC) reviews and evaluates information that can be “promotional” Areas Covered in the Seminar: Know relevant vocabulary. The DDMAC Strategic initiatives. Understanding DDMAC's perspective. Integrating strategies and tactics for your organization. DDMAC follow-up: what can happen. Who Will Benefit: This course is intended for anyone who has or will have a role in advertising, promotion and technical support within the FDA regulated field. It is especially useful for organizations that are just moving toward their first approval and individuals whose role has changed or expanded into this area. This webinar will be useful to anyone who works in: Marketing Sales Technical or Professional Services Regulatory Affairs Executive Management For More Details: http://complianceonline.com/ # # # Enhancing global compliance, creating a world where quality and compliance professionals, regulators, and government agencies come together to help the world comply with the intent and the spirit of laws, policies and mandates. End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|